中心簡介

Center Introduction

About Us / 中心現況與歷史

  • About CMUH-CTC

    The Chinese Medical University Hospital Clinical Trial Center (CMUH-CTC), previously Clinical Research Center, was officially renamed in 2008 to reflect and establish the undertaking of clinical trials as a primary mission and commitment of CMUH.

    Under the leadership of the current Director, Professor Chung Y. Hsu (2010-present), CMUH-CTC has been successfully awarded clinical trials and research funding by Taiwan’s Ministry of Health and Welfare for consecutive years.

    The management philosophy of Professor Hsu:

    Professor Hsu’s management of CMUH-CTC is rooted in his beliefs in prioritizing the needs and objectives of sponsors and principal investigators (PIs); providing top quality and optimized clinical trial services and solutions to industries at home and abroad; aiding in the discovery of new drugs and medical devices and facilitating their availability in the market.

     

    CMUH-CTC is a trusted collaborative partner to many global pharmaceutical companies and their contract research organizations (CROs). Our collaborators include Novartis, Pfizer, Sanofi, and many top 50 global pharma companies, with the list of partners in clinical trial excellence continuing to expand rapidly. As of Jane 2020, the center has contracted with more than 315 companies and undertaken over 1,000 cases of clinical research and trial.

  • Cooperative Partner

    CMUH-CTC is a trusted collaborative partner to many global pharmaceutical companies and their contract research organizations (CROs). Our collaborators include Novartis, Pfizer, Sanofi, and many top 50 global pharma companies, with the list of partners in clinical trial excellence continuing to expand rapidly. As of Jane 2020, the center has contracted with more than 315 companies and undertaken over 1,000 cases of clinical research and trial.

Professional Team

Li-Yuan Bai MDDeputy Director

Current Positions
  • Director, Division of Hematology and Oncology, China Medical University Hospital
  • Attending Physician, Division of Hematology and Oncology, China Medical University Hospital
  • Attending Physician, Department of Internal Medicine, Yilan Hospital
  • Internal Medicine, Taipei Veterans General Hospital (Yuli branch)
  • 美國Ohio State University 醫學研究所博士
  • MSc, School of Medicine, China Medical University
  • Faculty of Medicine, National Yang-Ming University
Experience

History of Development

Chronicles

Present-2016
  • 2019
  • 2018
    • 舉辦2018年台灣SCRS論壇。
    • 本院獲得JCI第二度認證通過,肯定本院管理以及對病患及受試者的服務已達國際最高標準。
    • 通過AAHRPP第二次認證,本院臨床試驗受試者保護深獲國際肯定。
  • 2017
    • 獲得衛生福利部106-108年「精進臨床試驗能量及國際躍昇」計畫。
    • 舉辦台灣首場SCRS(Society for Clinical Research Sites)論壇。
  • 2016
    • 許重義教授獲SCRS授權為台灣區大使,協助協會在台推廣。
    • 加入「國際臨床試驗組織」 (International Clinical Trials Center Network, ICN),為台灣唯一獲准加入的臨床試驗中心。
  • 2019 - 2023
    2013 - 2009